Children

Synbiotics by Probi® and Clasado

Synbiotics by Probi and Clasado combines the most researched probiotic strains with the most comprehensively studied galactooligosaccharide (GOS) prebiotic available on the market. Bimuno® GOS is supported by over 110 publications, including 20+ clinical trials, while Probi Digestis® and Probi Defendum® boasts over 250 publications, including 80+ clinical trials. These synbiotic concepts represent truly scientifically …

Synbiotics by Probi® and Clasado Read More »

Crescylia

Crescylia Children growth is based on L. plantarum WJL combined in a formulation with vitamin D, for the EU claim for normal growth and development of bone in children. It is a premium, stable (24 months at room temperature) probiotic available for distribution in many countries.

Lacidofil®

L. rhamnosus Rosell®-11 + L. helveticus Rosell®-52 Diarrhea, Antibiotic-Associated Diarrhea, H. pylori eradication therapy, Atopic Dermatitis Lactose intolerance in children and adults 2B CFU Atopic Dermatitis in children 2B CFU Antibiotic-associated diarrhea in children and in adults from 1B to 12B depending on age Adjunct to physician-supervised therapy in children and adults with Helicobacter pylori …

Lacidofil® Read More »

Probi Defendum®

Probi Defendum® is based on a combination of the probiotic strains Lactiplantibacillus plantarum HEAL9 (HEAL9™) and Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2™), equally contributing to the clinically documented dose of 1 billion (1 B) CFU per day. Several studies describe immune effects after intake of Probi Defendum® with findings on endpoints such as decreased incidence …

Probi Defendum® Read More »

Probi Digestis®

Probi Digestis® is based on the probiotic strain Lactiplantibacillus plantarum 299v (LP299V®). LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within areas reaching from …

Probi Digestis® Read More »

HappyBelly

HappyBelly is a probiotic complex by SynBalance, specifically designed to support children’s gastrointestinal health.HappyBelly has been clinically tested in a randomized double blind placebo controlled clinical trial.  100 IBS-C subjects were randomly divided in two groups 50 supplemented with a daily dose of 4B/ day for 60 days + 30 days of follow-up and 50 …

HappyBelly Read More »

Probi® Sensia

Probi® Sensia is based on L. plantarum HEAL9 (HEAL9™), a unique clinically documented probiotic strain developed by Probi® and protected by patents worldwide. Probi® Sensia impacts the mental processes relating to the input and storage of information and how that information is used to guide a person’s function and behavior. Randomized controlled studies have shown …

Probi® Sensia Read More »

Lactobacillus rhamnosus – GG (ATCC 53103)

Diarrhea • Rotaviral diarrhea • Gastroenteritis Also available as Active Pharmaceutical Ingredient (API) Autism and ADH prevention • Oral health • Caries prevention • Inhibition of Streptococcus mutans  

Lactobacillus salivarius I 1794

Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at …

Lactobacillus salivarius I 1794 Read More »

Lactobacillus paracasei I 1688

Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at …

Lactobacillus paracasei I 1688 Read More »

Bifidobacterium lactis Lafti® B94

The probiotic strain Bifidobacterium lactis Lafti® B94 has been specifically documented in the area of gut health. It benefits from a strong body of clinical evidence, supported by in vitro and in vivo documentation of its modes of action. A converging body of clinical evidence: digestive comfort Gut transit in all population groups (infants from birth, children, adolescents, adults): Bifidobacterium animalis …

Bifidobacterium lactis Lafti® B94 Read More »

Lactiplantibacillus plantarum WJL

L. plantarum WJL is a second precision probiotic developed by TargEDys in collaboration with the Functional Genomics Institute of Lyon, selected by its ability to optimize the amino acid absorption, by a stimulation of the somatotroic axis. The potenital of this strain is large: from children growth, elderly bones and muscle mass, sport nutrition to …

Lactiplantibacillus plantarum WJL Read More »

Lactobacillus rhamnosus CRL1505

A randomized, double-blind, placebo-controlled trial with 298 pre-school children (2-5 years old) that consumed CRL 1505® (0,1 billion CFU/day) or a placebo 5 days/week for 6 months showed that children in the probiotic group had a significantly lower number of infections during the study period. CRL 1505® intake lowered the incidence of upper respiratory tract …

Lactobacillus rhamnosus CRL1505 Read More »

Lactobacillus reuteri LR92

Lactobacillus reuteri LR 92 LR92 is the first and only probiotic strain that has clinically demonstrated to significantly reduce the incidence of infantile colic in the newborn child, when given, to the mothers, in the last months of pregnancy. By improving the health of the infant, LR 92 helps mothers to live more serenely during …

Lactobacillus reuteri LR92 Read More »

Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595)

Several studies have shown that Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) survives the passage through the GI tract, and attaches to the intestinal cells through a specific mannose-dependent binding mechanism. The bacteria can thereby exert its effects on the intestinal wall, and immune system. Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) has also been shown to …

Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) Read More »

Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594)

Several studies have shown that Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) can survive and persist in the gastrointestinal tract in humans. The strain was even recovered in the faeces in nearly all subjects up to 15 days after administration. Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) has been shown to support the immune system, as well …

Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) Read More »

Scroll to Top
Browse companies by type
Brought to you by